Newly approved MS treatment promises less daily medication for patients
NASHVILLE, Tenn. —
The FDA recently approved a treatment that promises less frequent medication for patients with multiple sclerosis.
Doctors say it treats both form of MS, and it's administered through a three-hour transfusion once a month.
Watch the video to hear from the first man to receive the treatment.